Abstract The efficacy and safety of photodynamic therapy (PDT) have drawn much attention from clinicians and researchers in the field of anticancer treatments since the last century. Despite the numerous positive outcomes, the works on PDT have brought to light over the last decades, much room remains for improvements in PDT tools, mainly on the photosensitizer molecules. This work reports the first experiments evidencing the photosensitizing activity of DHX-1, a xanthene derivative-based near-infrared probe recently described in the literature, both as a free molecule and associated to a nanostructured lipid carrier. The results show that the DHX-1 presents a broad band of light absorption within the optical window of biological tissues (600–800 nm), generates reactive oxygen species when photoactivated, and is phototoxic against murine breast adenocarcinoma 4T1 cells and murine fibroblast NIH-3T3 in vitro. Moreover, the association of DHX-1 to a nanostructured lipid carrier strongly reduced its phototoxicity against the normal cell line.
A xanthene derivative, free or associated to nanoparticles, as a new potential agent for anticancer photodynamic therapy
Kaiming Wang,Juan Zhang,Wellington Tavares de Sousa Júnior,Victor Carlos Mello da Silva,M. C. Rodrigues,J. A. V. Morais,Cheng-Shi Jiang,J. P. Longo,R. Azevedo,L. A. Muehlmann
Published 2020 in Journal of Biomaterials Science. Polymer Edition
ABSTRACT
PUBLICATION RECORD
- Publication year
2020
- Venue
Journal of Biomaterials Science. Polymer Edition
- Publication date
2020-06-26
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-27 of 27 references · Page 1 of 1
CITED BY
Showing 1-7 of 7 citing papers · Page 1 of 1